Medipost Co. Ltd. | Ownership
Companies that own Medipost Co. Ltd.
Hanwha Asset Management Co., Ltd.
388,754
4.94%
388,754
0.12%
03/06/2018
National Pension Service of Korea
280,586
3.57%
-117,866
0.02%
05/09/2018
The Vanguard Group, Inc.
170,869
2.17%
8
0%
07/31/2018
BlackRock Fund Advisors
86,909
1.11%
0
0%
09/05/2018
BlackRock Advisors (UK) Ltd.
66,700
0.85%
0
0%
09/06/2018
Mirae Asset Global Investments Co., Ltd.
15,185
0.19%
4,381
0.01%
04/30/2018
Norges Bank Investment Management
6,633
0.08%
-41,272
0%
12/31/2017
Charles Schwab Investment Management, Inc.
6,594
0.08%
0
0%
09/06/2018
SSgA Funds Management, Inc.
4,548
0.06%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
4,462
0.06%
0
0%
03/31/2018
| Address |
21 Daewangpangyo-ro 644 beon-gil
Seongnam GY 13494
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.medi-post.co.kr |
| Updated |
09/14/2018 |
| Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. It operates through the following business divisions: Cord Blood Bank, Stem Cell Therapy, Health Functional Food, Import and Distribution of Natural Cosmetics and Healthcare Services. The Cord Blood Bank division is involved in collecting and storing stem cells from the newborn's umbilical cord. |
